Article

A comprehensive review of assay methods to determine drugs in breast milk and the safety of breastfeeding when taking drugs

Unitat de Recerca Infància i Entorn (URIE), Institut Municipal d'Investigació Mèdica (IMIM)-Hospital del Mar, 08003 Barcelona, Spain.
Analytical and Bioanalytical Chemistry (Impact Factor: 3.58). 04/2010; 397(3):1157-79. DOI: 10.1007/s00216-010-3681-0
Source: PubMed

ABSTRACT Most of the licit and illicit drugs consumed by the breastfeeding woman pass into the milk and can modify the production, volume and composition of the milk, as well as hypothetically have short- and long-term harmful effects on the infant. There is much confusion in the scientific community regarding this issue: should a woman breastfeed her baby while continuing to use prescription drugs and/or drugs of abuse? There are many case reports of clinically significant toxicity in breast-fed infants from some substances used by mothers (such as irritability, vomiting, sedation, respiratory depression, shock), but there are too few data on studies conducted in breastfeeding women and their infants to make a realistic risk assessment. The objective measurement of a drug and/or metabolites in maternal milk is the first step when investigating the amount of drug excreted in milk and subsequently calculating the daily dose administered to the breast-fed infant. The present review reports the analytical methods developed to detect different drugs in the breast milk, listing the principal characteristics and validation parameters, advantages and disadvantages. Furthermore, the mechanisms of drug transfer into breast milk are discussed, the correlation between the concentration of the drug in breast milk and potential adverse outcomes on the infant are described for each drug, and suggested harm minimization strategies and approved breastfeeding recommendations are indicated.

Download full-text

Full-text

Available from: Oscar Garcia-Algar, Jul 28, 2014
2 Followers
 · 
247 Views
  • Source
    • "These results are in accordance with previous studies [16] [17] [18] [19], where CAF in breast milk from CAF-consuming mother was between 47 and 4000 ng/mL. CAF is considered compatible with breastfeeding [7] because occasional use appears to have little effects on infant but it would seem advisable to restrict caffeine consumption to less than 300 mg/day (approximately three cups of coffee) while breastfeeding [1]. With respect to the 34 milk samples collected and analyzed before and after pasteurization process, no difference in concentration of CAF, the only analyte found in few of these samples, was highlighted and none of the other psychoactive drugs were determined before or after the process. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A liquid chromatography tandem mass spectrometry (LC-MS-MS) method for the quantification of frequently used licit (caffeine, nicotine and cotinine) and illicit drugs (opiates, cocaine, cannabinoids and amphetamines) in breast milk was developed and fully validated. Chromatography was performed on a reverse-phase column using a gradient of 2mM ammonium acetate, pH 6.6, and methyl alcohol as mobile phase at a flow rate of 0.35 mL/min. Separated analytes were quantified by electrospray ionization tandem mass spectrometry in positive ion mode using multiple reaction monitoring. Milk samples were kept at -20 °C until analysis and the compounds under investigation were extracted from the matrix by Bond Elut Certify cartridges. The concentration range covered was LOQ to 1000 ng/mL for all the investigated drugs. Intra- and inter-assay imprecision was less than 20%, analytical recovery ranged between 51.6% and 86.5%, matrix effect between 71.1% and 116.6% and process efficiency between 46.8% and 84.0%. Analytes were stable after three freeze-thaw cycles, after 6 months at -20 °C and after the pasteurization process (differences to the initial concentration always lower than 10%). matrix effect ranged from 77.6% to 116.6%, recovery from 51.6% to 86.5%, and process efficiency from 46.8% to 79.0%. This LC-MS-MS assay was applied to screen samples from the largest Spanish milk bank and samples coming from drug addicted mothers. The developed method provided adequate sensitivity and performance characteristics to prove the presence of only caffeine in a small percentage of samples from milk donating nursing mothers and the presence or absence of most commonly used illicit drugs in breast milk from addicted lactating mothers.
    Journal of pharmaceutical and biomedical analysis 05/2011; 55(2):309-16. DOI:10.1016/j.jpba.2011.01.028 · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ferrite devices employing the field displacement principle or ferromagnetic resonance are difficult to build in the millimeter wavelength region because of the high magnetic fields usually required for biasing the ferrite. In conventional ferrites, the upper limit of the saturation magnetization, 4piM<sub>s</sub>, is about 6000 gauss. For resonance with the most favorable ferrite shape, namely, a thin slab magnetized in the direction of one of its longer dimensions, the Kittel relation for resonance becomes, f = γ √
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This work is a three-dimensional stability study based on the modal analysis for a continuous beam with a Kapchinskij-Vladimirskij (KV) distribution. The analysis is carried out self-consistently within the context of linearized Vlasov-Maxwell equations and electrostatic approximation. The emphasis is on investigating the coupling between longitudinal and transverse perturbations in the high-intensity region. The interaction between the transverse modes supported by the KV distribution and those modes sustainable by the cold beam is examined. We found two classes of coupling modes that would not exist if the longitudinal and the transverse perturbations are treated separately. The effects of wall impedance on beam stability is also studied and numerical examples are presented
    Particle Accelerator Conference, 2003. PAC 2003. Proceedings of the; 06/2003
Show more